Pyxis Oncology, Inc.

Ownership Transactions Reported by 20 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+41.4 K	53.1%	$1.77	+$73.4 K
Sells	1	-36.6 K	46.9%	$2.23	-$81.5 K
Net	+1	+4.87 K	6.2%		-$8.02 K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Pfizer Inc	10%+ Owner	$19.4 M			Mar 17, 2023
Lara Sullivan	Chief Executive Officer, Director	$7.47 M	-$81.5 K	-1.08%	Mar 26, 2024
Barclays Plc	10%+ Owner	$4.87 M			Apr 26, 2022
Bayer World Investments B.V.	Former 10% Owner	$3.84 M			Oct 13, 2021
Cormorant Asset Management, LP	Former 10% Owner	$1.57 M			Oct 13, 2021
Jakob Dupont	Director	$1.56 M			Mar 26, 2024
Pamela Ann Connealy	Cfo & Coo	$1.55 M	+$55.6 K	+3.71%	Mar 26, 2024
Jay Feingold	Chief Medical Officer	$1.09 M			Mar 24, 2023
John Flavin	Director	$578 K			Mar 26, 2024
Jitendra Wadhane	SVP, Chief Accounting Officer	$558 K	+$17.9 K	+3.31%	Mar 26, 2024
Ken Kobayashi	Chief Medical Officer	$425 K			Dec 29, 2023
Darren S. Cline	Director	$352 K			Mar 26, 2024
Freda C. Lewis-Hall	Director	$338 K			Mar 26, 2024
Michael A. Metzger	Director	$271 K			Jun 10, 2024
Santhosh Palani	Director	$267 K			Jun 7, 2024
Ronald Herbst	Chief Scientific Officer	$235 K			Oct 7, 2021
Thomas Civik	Director	$169 K			Mar 26, 2024
Rachel Humphrey	Director	$136 K			Mar 26, 2024
Ritu Shah	Chief Operating Officer	$120 K			Oct 7, 2021
Mark Chin	Former Director				Apr 21, 2022

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership